CD8A and neoplasm: When exhibiting a pro-tumor M2 phenotype, TAMs are characterized by high levels of arginase 1 (ARG1), which depletes L-arginine within the TME, thus effectively suppressing CD8+ T cell activation through arginine metabolism.